Turning to the term “antibody fragments,” the Federal Circuit held that the district court erred its construction by again relying too heavily on a specific portion of the specification.

The antibody or antibody fragment according to claim 1, wherein said antibody or antibody fragment is selected from the group consisting of a monoclonal antibody, a chimeric antibody, a humanized ...

Novel small antibody fragment: ... Antibodies recognize a specific antigen unique to its target as they possess the antigen-binding sites located at the upper tips of the Y.

Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide.

We present a bispecific antibody that recognizes an antigen and a hapten and can be applied to various biological assays, including immunoblotting and immunoprecipitation. In immunoblot analysis ...

Numab’s preclinical-stage anti-tumor necrosis factor (TNF) antibody fragment ND009 is in development against inflammatory bowel disease and is licensed to Tillotts Pharma.